Search bioRxiv⌕ Search

bioRxiv · 10.1101/2022.05.04.490568

An autonomous mathematical model for the mammalian cell cycle

Abstract

A mathematical model for the mammalian cell cycle is developed as a system of 13 coupled nonlinear ordinary differential equations. The variables and interactions included in the model are based on detailed consideration of available experimental data. Key features are that the model is autonomous, except for dependence on external growth factors; variables are continuous in time, without instantaneous resets at phase boundaries; cell cycle controllers and completion of tasks associated with cell cycle progression are represented; mechanisms to prevent rereplication are included; and cycle progression is independent of cell size. Eight variables represent cell cycle controllers: Cyclin D1 in complex with Cdk4/6, APCCdh1, SCF{beta}Trcp, Cdc25A, MPF, NUMA, securin-separase complex, and separase. Five variables represent task completion, with four for the status of origins and one for kinetochore attachment. The model predicts distinct behaviors consistent with each main phase of the cell cycle. The response to growth factors shows restriction-point behavior. These results imply that the main features of the mammalian cell cycle can be accounted for in a quantitative mechanistic way based on known interactions among cycle control factors and their coupling to tasks involved in replication of DNA. The model is robust to parameter changes, in that cycling is maintained over at least a five-fold range of each parameter when varied individually. The most sensitive parameters are those associated with the initiation and completion of mitosis. The model is suitable for exploring how extracellular factors affect cell cycle progression, including responses to metabolic conditions and to anti-cancer therapies. Author SummaryWe created a model, that is, a set of mathematical equations, to represent the entire cell cycle in mammals. All terms in our equations correspond to actual biological mechanisms. We solved the equations and verified that they show similar behavior to real-life cell cycles. We designed our model to cycle only when enough external growth factors stimulate it, as real cells do. Our model helps us better understand how the cell cycle is controlled. One very important aspect of control is how the cell ensures that its DNA is copied only once per cell cycle. If "rereplication" (copying a section of DNA twice in the same cycle) occurs, it can cause harmful DNA damage. We considered several mechanisms that some biologists believe play a role, and found that most could not explain how rare rereplication is. Two mechanisms did work well, and we used them to make two variants of the model, which show similar behavior. The model has many potential applications. The cell cycle is altered in most cancer cells, so understanding how these changes affect control is useful. Many widely-used drugs affect the cell cycle, and our model can be used to study these effects.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Williams, K. S., Secomb, T. W., El-Kareh, A. W.. 2022-05-04. An autonomous mathematical model for the mammalian cell cycle. https://doi.org/10.1101/2022.05.04.490568

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Sequence context and partner availability specify divergent cell fates from a single transcription factor

Transcription factors drive the gene regulatory networks that control developmental transitions, yet which of their many targets a cell uses remains unresolved. Expressing Cebp, Cebp{beta} or Cebp{delta} identically, alone or with Oct4, Sox2, Klf4 and cMyc, gave four outcomes: adipocyte from fibroblasts and neural stem cells, trophectoderm from embryonic stem cells, and myeloid from B cells. Raising Cebp levels changed how many sites it reached, not which sequence it read: clustered motifs maintained somatic enhancers, while spillover onto low-copy sites created de novo enhancers carrying composites of Cebp and cell-type-restricted partners. In fibroblasts, Cebp also redistributed Oct4, Sox2 and Klf4 from early targets, blocking iPSC formation. Supplying the predicted partners rewrote the output: Spi1 redirected Cebp into parallel adipogenic and myeloid programs, via a transient PpargCD45 state using separate enhancers for each; TFAP2C abolished adipogenic conversion. Motif density and partner composites therefore assemble a factor's instructive output in the receiving cell.

cell biology↗

High-content screening identifies FDA-approved activators of mitophagy

Mitochondrial diseases are highly heterogeneous disorders caused by defects in oxidative phosphorylation, for which only limited therapeutic options are available. The elimination of dysfunctional mitochondria via mitophagy activation is an attractive strategy to treat several mitochondrial diseases, irrespective of the underlying genetic defect. To identify pharmacological activators of this pathway, we performed a high-content screening of 1,971 FDA-approved compounds using cellular reporters of TFEB nuclear translocation and mitophagy. This screening identified 294 compounds that promoted TFEB translocation, nine of which increased the number of mitolysosomes without compromising cell viability or damaging mitochondria. Among the selected compounds, Meptazinol and Ponatinib emerged as the top-ranked mitophagy inducers in fibroblasts from patients with complex I and IV deficiency, respectively, and were prioritised for further characterisation. However, they did not rescue the bioenergetic defect, suggesting that the stimulation of mitophagy per se is not sufficient to ameliorate the OXPHOS defect in mitochondrial diseases. Overall, our findings establish a scalable platform for the identification of pharmacological activators of TFEB and identify candidate compounds for therapeutic modulation of mitophagy.

cell biology↗

Matrix Gla Protein deficiency reveals a previously unrecognized mucosal calcification in the mouse airways

Tracheal calcification is a common finding that is considered to have limited clinical significance when detected most often in elderly individuals. Despite its frequent occurrence, the cellular and molecular mechanisms at the origin of tracheal calcification remain largely unexplored. In this context, we aimed to characterize the development of tracheal calcification, and to determine the role of matrix Gla protein (MGP), a major inhibitor of ectopic calcification whose genetic or pharmacologic deficiency is associated with premature tracheal calcification in humans. We found that wild-type mice undergo an unexpected early physiologic calcification of the tracheal cartilage rings beginning around one month after birth. This calcification progresses in a dynamic rostro-caudal sequence through a process involving terminal differentiation of tracheal chondrocytes. These findings challenge the prevailing view that tracheal cartilage is a permanent hyaline cartilage and instead reveals an early and highly organized physiologic calcification process. Furthermore, our findings further identify MGP as a key regulator of calcification within the respiratory tract. Indeed, MGP deficiency not only markedly accelerates tracheal cartilage calcification through a similar pattern and mechanism but also induces a previously unrecognized calcification of the tracheal mucosa, a lesion absent in wild-type mice. These alterations could partly explain the respiratory manifestations observed in MGP-deficient patients having Keutel syndrome, which include dyspnea, cough, stridor, and recurrent infections, symptoms previously being mainly attributed to calcification of the tracheal cartilage rings.

cell biology↗